SHIFT AI Newsroom · GLOBAL
Trial Investigates HMB and Vitamin D for Preserving Muscle in Older Adults on Semaglutide
A clinical trial is examining the potential of HMB plus Vitamin D to preserve muscle mass in older adults who are starting Semaglutide treatment.
A clinical trial registered on ClinicalTrials.gov is investigating the potential of HMB (beta-Hydroxy beta-Methylbutyrate) plus Vitamin D to preserve muscle mass in older adults who are starting Semaglutide treatment. The trial's outcomes may provide insights into the management of muscle health in this population. However, the trial's results and any subsequent regulatory approvals will determine the relevance and potential impact of this intervention in the UK.
What this means in the UK
This trial may have implications for the management of muscle health in older adults in the UK who are starting Semaglutide treatment, but its relevance and potential impact depend on the trial's outcomes and subsequent regulatory approvals.
Known facts
- A clinical trial is investigating the use of HMB plus Vitamin D to preserve muscle in older adults starting Semaglutide.